Finance Watch: FOPO Surge Continues With Big Offerings From Revolution, NewAmsterdam
Jupiter Closes 25th Biopharma IPO In US For 2024
Public Company Edition: Revolution Medicines grossed $862.5m and NewAmsterdam raised $479m in follow-on public offerings, continuing this year’s rise in FOPOs. Janux, CG Oncology, Rocket, ImmunityBio, Protara and Candel also recently raised significant follow-on cash.